Oscar Health Inc. (NYSE: OSCR) reported Q1 EPS of $0.62, $0.35 better than the analyst estimate of $0.27. Revenue for the quarter came in at $2.1 billion versus the consensus estimate of $1.99 billion.

Oscar is reaffirming its full year 2024 outlook across all metrics as provided in its financial results press release dated February 7, 2024.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.